Can You Take Antacids with Wegovy? Safety and Guidance

Can you take antacids with Wegovy? Yes, antacids can generally be taken alongside Wegovy (semaglutide) without specific interactions. Wegovy is administered as a subcutaneous injection, whilst antacids work locally in the stomach to neutralise acid. However, Wegovy can delay gastric emptying, which may worsen reflux-like symptoms in some individuals. Many people taking Wegovy experience gastrointestinal side effects, including nausea, indigestion, and acid reflux, particularly during initial treatment or dose increases. If you experience persistent digestive discomfort whilst taking Wegovy, discuss this with your GP or pharmacist before routinely using antacids to ensure symptoms do not require further assessment.

Can You Take Antacids with Wegovy?

Yes, you can generally take antacids alongside Wegovy (semaglutide). There is no specific interaction between antacids and Wegovy listed in the UK Summary of Product Characteristics (SmPC). Wegovy is administered as a subcutaneous injection, while antacids work locally in the stomach to neutralise acid.

However, it's important to understand that Wegovy can delay gastric emptying, which may worsen reflux-like symptoms in some people. Many people taking Wegovy experience gastrointestinal side effects, including nausea, indigestion, and acid reflux, which may prompt them to reach for over-the-counter remedies. These symptoms are common, particularly during the initial weeks of treatment or following dose increases.

For symptom relief, both traditional antacids (containing calcium carbonate, magnesium compounds) and alginate-based products (which form a protective layer on top of stomach contents) may be helpful options.

If you are experiencing persistent digestive discomfort whilst taking Wegovy, it is advisable to discuss this with your GP or pharmacist before routinely using antacids. They can help determine whether your symptoms are a normal side effect of the medication, require dose adjustment, or indicate another underlying condition that needs investigation. Self-medicating with antacids for prolonged periods without medical advice may mask symptoms that warrant further assessment, such as gastro-oesophageal reflux disease (GORD) or peptic ulcer disease.

Mounjaro®

Average 22.5% body weight loss

Mounjaro® is the most innovative GLP-1 medication proven to dramatically curb appetite, hunger, and cravings to help professional men achieve substantial weight loss.

Start Here

Wegovy®

Average 16.9% body weight loss

Wegovy® is a weekly injectable GLP-1 medication with proven effectiveness in reducing appetite, hunger, and cravings to help busy professionals lose significant weight.

Start Here

Find out if you’re eligible

How Wegovy Works and Potential Interactions

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management and now licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities. Semaglutide works by mimicking the action of the naturally occurring hormone GLP-1, which is released from the gut in response to food intake. It enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through effects on the central nervous system.

The slowing of gastric emptying is particularly relevant when considering potential interactions. Because Wegovy delays how quickly food and medications leave the stomach, it could theoretically affect the absorption of oral medications. However, according to the Wegovy SmPC, clinical studies have shown no clinically relevant effect on the rate of absorption of oral medications including paracetamol, atorvastatin, digoxin, metformin, oral contraceptives, and warfarin.

For antacids specifically, there is no evidence suggesting that Wegovy alters their effectiveness or safety profile. Antacids work topically within the stomach to neutralise hydrochloric acid, rather than requiring systemic absorption.

If you are taking warfarin alongside Wegovy, more frequent monitoring of INR (International Normalised Ratio) is recommended when initiating semaglutide treatment, as noted in the SmPC. For other medications, the primary consideration is ensuring that antacids themselves do not interfere with the absorption of any other oral medications you may be taking concurrently.

Timing Antacids and Wegovy: What You Need to Know

Because Wegovy is administered as a once-weekly subcutaneous injection, there are no direct timing concerns between the injection and antacid use. Unlike oral medications that must be carefully spaced to avoid interactions in the gastrointestinal tract, Wegovy enters the bloodstream directly through injection, typically in the abdomen, thigh, or upper arm. This means you can take antacids at any time relative to your Wegovy injection without affecting the medication's absorption or efficacy.

However, if you are taking other oral medications alongside Wegovy, standard guidance for antacid use still applies. Most antacids can interfere with the absorption of certain medications by altering stomach pH or binding to drugs in the gut. The timing between antacids and other medications varies by drug class and specific product. Medications that may be affected include:

• Antibiotics (tetracyclines typically need 2-3 hours separation; quinolones often require 2 hours before or 4-6 hours after antacids)

• Bisphosphonates (for osteoporosis, require strict fasting administration)

• Thyroid hormones (levothyroxine)

• Iron supplements

• Some cardiac medications (digoxin)

It's best to check the Patient Information Leaflet for your specific medications or consult your pharmacist for personalised advice on timing, as requirements differ between medicines.

If you experience acid reflux or indigestion symptoms that seem related to the timing of your Wegovy injection, this is more likely due to the medication's effect on gastric emptying rather than a direct interaction. Taking antacids or alginate-based products when symptoms occur is appropriate, but if you find yourself needing them frequently, this warrants discussion with your healthcare provider about whether dose adjustment or additional management strategies are needed.

Managing Digestive Symptoms While Taking Wegovy

Gastrointestinal side effects are among the most commonly reported adverse reactions to Wegovy, affecting a significant proportion of users, particularly during treatment initiation and dose escalation. The most frequent symptoms include nausea (reported in up to 44% of patients according to the SmPC), vomiting, diarrhoea, constipation, abdominal pain, and dyspepsia. These effects are generally mild to moderate in severity and tend to diminish over time as the body adjusts to the medication.

Whilst antacids can provide symptomatic relief for acid-related discomfort, a comprehensive approach to managing digestive symptoms is recommended:

• Dietary modifications: Eating smaller, more frequent meals rather than large portions can help reduce nausea and bloating. Avoiding high-fat, spicy, or heavily processed foods may also minimise gastrointestinal upset.

• Adequate hydration: Drinking plenty of water throughout the day supports digestion and can help prevent constipation, another common side effect.

• Meal timing: Some patients find that injecting Wegovy on a day when they can rest and manage symptoms more easily (such as a weekend) helps during the adjustment period.

• Gradual dose escalation: The Wegovy SmPC emphasises the importance of following the prescribed dose escalation schedule, which is designed to improve tolerability.

If antacids alone are insufficient to manage reflux or indigestion symptoms, your GP may consider prescribing a proton pump inhibitor (PPI) such as omeprazole or lansoprazole, or an H2 receptor antagonist like famotidine. Alginate-based products (such as Gaviscon) may also be helpful for reflux symptoms as they form a protective layer on top of stomach contents. These medications provide more sustained acid suppression than antacids and may be more appropriate for persistent symptoms. However, they should only be used under medical supervision, as prolonged PPI use carries its own considerations regarding nutrient absorption and potential side effects.

When to Speak to Your GP or Pharmacist

Whilst mild digestive discomfort is expected with Wegovy, certain symptoms warrant prompt medical attention. You should stop taking Wegovy and contact your GP or seek urgent medical advice if you experience:

• Severe or persistent abdominal pain, particularly if localised to the upper abdomen or accompanied by back pain and/or vomiting (potential signs of pancreatitis, a rare but serious side effect)

• Persistent vomiting that prevents you from keeping down fluids or medications

• Signs of dehydration, including dark urine, dizziness, or reduced urination

• Blood in vomit or stools, or black, tarry stools (potential indicators of gastrointestinal bleeding)

• Severe heartburn or difficulty swallowing that does not respond to antacids

• Progressive difficulty swallowing (dysphagia)

• Symptoms of gallbladder disease, such as pain in the upper right abdomen, particularly after eating fatty meals

You should also consult your pharmacist or GP if you find yourself using antacids daily for more than two weeks. Persistent symptoms may indicate that your digestive issues require further investigation or alternative management strategies. Your healthcare provider can assess whether your symptoms are within the expected range for Wegovy or whether they suggest conditions such as GORD, peptic ulcer disease, or gallstones, which are more common in people with obesity and may require specific treatment.

Additionally, if you are taking multiple medications, a medication review with your pharmacist is valuable to ensure there are no interactions between your antacids and other treatments. Your pharmacist can advise on the most appropriate type of antacid for your needs and optimal timing to avoid any potential absorption issues with other medications.

If you experience any suspected side effects from Wegovy, you can report these through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk). Remember that your healthcare team is there to support you throughout your weight management journey, and open communication about side effects is essential for safe and effective treatment.

Frequently Asked Questions